LivaNova PLC (LIVN)
NASDAQ: LIVN · IEX Real-Time Price · USD
52.91
-0.19 (-0.36%)
At close: Jul 19, 2024, 4:00 PM
52.82
-0.09 (-0.17%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
LivaNova Employees
LivaNova had 2,900 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
2,900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$408,634
Profits / Employee
-$10,954
Market Cap
2.87B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2,900 | 0 | - |
Dec 31, 2022 | 2,900 | -100 | -3.33% |
Dec 31, 2021 | 3,000 | -1,000 | -25.00% |
Dec 31, 2020 | 4,000 | 0 | - |
Dec 31, 2019 | 4,000 | 0 | - |
Dec 31, 2018 | 4,000 | -500 | -11.11% |
Dec 31, 2017 | 4,500 | 0 | - |
Dec 31, 2016 | 4,500 | -200 | -4.26% |
Dec 31, 2015 | 4,700 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
ICU Medical | 14,000 |
Envista Holdings | 12,800 |
Azenta | 3,500 |
Tandem Diabetes Care | 2,400 |
agilon health | 1,117 |
ACADIA Pharmaceuticals | 598 |
MorphoSys AG | 524 |
Denali Therapeutics | 445 |
LIVN News
- 1 day ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVN - GlobeNewsWire
- 7 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LivaNova PLC - LIVN - Accesswire
- 27 days ago - Federman & Sherwood Investigates LivaNova USA, Inc. for Data Breach - Business Wire
- 4 weeks ago - LivaNova to Announce Second-Quarter 2024 Results - Business Wire
- 6 weeks ago - LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients - Business Wire
- 2 months ago - LivaNova to Present at the Goldman Sachs Healthcare Conference - Business Wire
- 2 months ago - LivaNova Reports First-Quarter 2024 Results - Business Wire
- 2 months ago - LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer - Business Wire